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The other measures that discriminated between those reaching the MCID
and those who did not were cartilage volume and thickness of total
medial femorotibial compartment. The Figure illustrates SRM thresholds
corresponding to the MCID in cartilage morphology measurements,
where the differences between those who achieve worsening deﬁned
by MCID were statistically signiﬁcantly different (p< 0.05) from those
who did not. MCID for cartilage volume loss over the central medial
femoral and medial femorotibial compartment was estimated at 6.6%
and 6.7% respectively. MCID for cartilage thickness loss in the central
medial femoral compartment was estimated at 6.3% including denuded
area and 3.3% excluding it. These 3–7% losses correspond to SRMs (mean
change / SD change) of approximately 0.5 to 0.65 (Figure).
Figure: Changes over 24 months in cartilage morphology stratiﬁed by
achieving MCID in functional worsening.
Conclusions: These data offer clinically meaningful thresholds in
quantitative cartilage morphology changes measured by MRI. Planning
clinical trials based on changes in cartilage volume and thickness in the
central medial femur may lead to the most efﬁcient design in terms of
sample size.
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Purpose: Magnetic resonance imaging (MRI) has become the tool of
choice for the assessment of knee osteoarthritis (OA) structural changes
and disease severity in cross-sectional and longitudinal studies. Amongst
methods currently used for cartilage evaluation are semiquantitative
scoring systems and quantitative volumetry. For the former method, MRI
sequences vary greatly among studies and are subject to debate. This
study aimed to evaluate both the impact of the choice of MRI sequences
on the cartilage defect assessment and the sensitivity to change of
semiquantitative and quantitative methods.
Methods: Post-hoc analysis of the MR image database of two recent
clinical trials in knee OA (Cohort 1, n = 24 and Cohort 2, n = 143[1]) was
performed. Standard inclusion and exclusion criteria were employed. For
both cohorts, a gradient echo fat suppressed T1-weighted (T1) sequence
was used, and patients of Cohort 1 underwent an additional fast spin
echo fat suppressed proton density (PD) sequence. MR images were
performed at baseline and 2 years. Cohort 2 included patients from
a trial examining the chondroprotective effect of licofelone (200mg
bid) versus naproxen (500mg bid)[1]. Cohort 1 was used to assess
the impact of the two MRI sequences on cartilage defect scores, and
Cohort 2 to evaluate, for the two methods, the sensitivity to change and
detectability of the treatment effect. The cartilage defects and cartilage
volume were evaluated using the semiquantitative WORMS[2] method
and the proprietary software Cartiscope™[3], respectively, on the same
patient. Evaluation was performed for the global knee (GK) as well as
medial (MC) and lateral (LC) compartments and subregions. Statistical
analysis for Cohort 1 included the Wilcoxon signed rank test and for
Cohort 2 the Student’s t-test and the standardized response mean (SRM)
of change.
Results: In Cohort 1, the cartilage defect assessment provided consistent
and signiﬁcantly higher scores in PD than in T1 sequences both at
baseline and 2 years (p < 0.001). Interestingly, in all regions studied,
the change from baseline to 2 years was not signiﬁcantly different
(p≥0.377). In Cohort 2, the SRM for the cartilage defects and volume loss
were respectively 0.365 and 2.000 for GK; 0.293, 1.473 MC; and 0.252,
1.165 LC, indicating that the quantitative cartilage volume evaluation
demonstrated greater sensitivity to change. With regard to treatment
effect, data revealed no signiﬁcant difference in cartilage defect score
change over 2 years between the two treatment groups, while the
change in cartilage volume loss demonstrated a signiﬁcant difference
in GK (p =0.009) and LC (p =0.026) as previously published[1].
Conclusions: OA cartilage defects assessed with the PD MRI sequence
showed a higher score than T1 in cross-sectional evaluation. However,
neither of the MRI sequences demonstrated superiority in assessing
cartilage defect change over time; therefore both are valuable for
evaluating cartilage lesions cross-sectionally. With regard to clinical
DMOAD trials, quantitative assessment of cartilage volume loss is more
sensitive than the semiquantitative method for the evaluation of changes
in OA cartilage lesions over time.
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Purpose: Prevention of osteoarthritis (OA) may be achieved through
modiﬁcation of life style parameters; among these obesity and metabolic
syndrome are of particular interest. T2 relaxation time measurements
of hyaline cartilage provide information on cartilage water content and
collagen degradation; these measurements provide an early assessment
of cartilage degeneration, before there is structural cartilage loss. The
aim of this study was to study how individual facets of the metabolic
syndrome are associated with cartilage degenerative changes measured
with T2 values at the knee using 3T MR images in middle-aged
individuals from the Osteoarthritis Initiative (OAI) incidence cohort
without radiographic osteoarthritis.
Methods: MR images of right knees of 405, 45–60 year old individuals
(n = 205 male, n = 200 female) with risk factors for osteoarthritis but
without knee pain and without radiographic ﬁndings for osteoarthritis
(K/L score 0 and 1) were analyzed. Cartilage segmentation was performed
in ﬁve compartments (patella, medial tibia, lateral tibia, medial femoral
condyle, lateral femoral condyle) and T2 relaxation time maps were
generated. Factors analyzed included diabetes mellitus type II (DM, self-
reported), body mass index (BMI), abdominal circumference, diastolic
and systolic blood pressure, as well as fat content of nutrition.
Additionally nicotine consumption and alcohol consumption were
evaluated. Statistical signiﬁcance was determined by using analysis
of variance and corrected for differences in age, gender and OA risk
factors other than BMI (eg, history of knee injury, family history of
knee replacement, Herbeden nodes in hands) in a multivariate linear
regression model.
Results: As shown in Figure 1 signiﬁcantly increased cartilage T2 values
were found in individuals presenting with DM (P=0.0122) and systolic
hypertension (P = 0.0464), but not for high diastolic blood pressure.
BMI and abdominal circumference showed the strongest effect on
T2 changes, which were most prominent in the medial compartment
(P < 0.0001; Figure 2). While general alcohol consumption had no effect,
increased beer consumption showed a non-signiﬁcant trend (P = 0.0602).
Neither nicotine consumption nor pack years of cigarette smoking were
